Alibaba Health Information Technology Ltd

0241.HK · Technology Services · Packaged Software · HK

884 employees · alihealth.cn

About

Alibaba Health Information Technology Ltd is one of the largest healthcare companies in China and is part of the Alibaba Group. The company was founded in 2014 and offers a wide range of healthcare services and products. Alibaba Health relies on state-of-the-art technologies and innovative business models. The history of Alibaba Health began with the founding of the online pharmacy shop Tmall Pharmacy in 2012, which was part of the Alibaba Group. Through collaborations with renowned healthcare companies such as Peking Tong Ren Tang and Shanghai Hutchison Pharmaceuticals, the online trading of medications in China was revolutionized. In 2014, the company was renamed Alibaba Health Information Technology Ltd and spun off as an independent subsidiary. The business model of Alibaba Health is based on a combination of online platforms, as well as sales and development of technologies and products in the healthcare field. The company offers a wide range of healthcare services, including electronic health records (EHR), cloud-based medical diagnosis and evaluation services, and digital over-the-counter medications. Through partnerships with leading healthcare institutions and medical facilities in China, Alibaba Health is able to offer customers comprehensive and high-quality medical care. An important division of the company is Alibaba Health Cloud, which provides a range of cloud-based medical services. These include medical imaging, artificial intelligence (AI) supported facial recognition, medical monitoring sensors, as well as online consultations with medical professionals. Alibaba Health also operates an online consultation portal where customers can seek expert advice from highly qualified specialist doctors. The portal is equipped with an automated diagnosis engine that helps patients identify their symptoms and offers recommended treatment options. Alibaba Health also has a growing presence in the field of pharmaceutical research and development. The company closely collaborates with major pharmaceutical companies such as Roche and Novartis to explore and develop innovative drugs and therapies. As part of these efforts, Alibaba Health recently announced a partnership with Chinese biotechnology company BeiGene to work together on the development of new cancer therapies. Another important area of the company is the sale of over-the-counter (OTC) medications. The company sells these medications online on Tmall Pharmacy as well as in physical stores. The products range from dietary supplements and vitamins to skincare products and pain relievers. In summary, Alibaba Health is a leading company in the field of healthcare services and products in China. The company utilizes state-of-the-art technologies and innovative business models to offer customers a comprehensive range of services and products. From electronic health records and cloud-based medical diagnosis services to online consultations and over-the-counter medications, Alibaba Health is a key player in the Chinese healthcare market.

Annual results

Reported figures, CNY · revenue up 13.2% in 2025

YearRevenueNet incomeNet marginFree cash flow
202530.6B1.4B4.7%—
202427.0B883M3.3%—
202326.8B535M2.0%—
202220.6B-265M-1.3%—
202115.5B348M2.2%—

Dividends per share

1998 0.07 CNY1997 0.10 CNY1996 0.02 CNY1995 0.15 CNY1994 0.33 CNY

0241.HK in MarketPulse

The live chart with RSI and moving averages, the price, news, signals and price alerts for Alibaba Health Information Technology Ltd are inside MarketPulse — currently in private beta.

Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.

Alibaba Health Information Technology Ltd (0241.HK) — company profile and financials · MarketPulse